DE68910999T2 - 1,2,3,4-Tetrahydroisoquinoline, Verfharen zu ihrer Herstellung und ihre Verwendung als Kappa-Rezeptor Agonisten. - Google Patents

1,2,3,4-Tetrahydroisoquinoline, Verfharen zu ihrer Herstellung und ihre Verwendung als Kappa-Rezeptor Agonisten.

Info

Publication number
DE68910999T2
DE68910999T2 DE89301374T DE68910999T DE68910999T2 DE 68910999 T2 DE68910999 T2 DE 68910999T2 DE 89301374 T DE89301374 T DE 89301374T DE 68910999 T DE68910999 T DE 68910999T DE 68910999 T2 DE68910999 T2 DE 68910999T2
Authority
DE
Germany
Prior art keywords
alkyl
group
hydrogen
same
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89301374T
Other languages
English (en)
Other versions
DE68910999D1 (de
Inventor
Vittorio Vecchietti
Giuseppe Giardina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
Smithkline Beecham Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888803919A external-priority patent/GB8803919D0/en
Priority claimed from GB888815089A external-priority patent/GB8815089D0/en
Application filed by Smithkline Beecham Farmaceutici SpA filed Critical Smithkline Beecham Farmaceutici SpA
Publication of DE68910999D1 publication Critical patent/DE68910999D1/de
Application granted granted Critical
Publication of DE68910999T2 publication Critical patent/DE68910999T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DE89301374T 1988-02-19 1989-02-14 1,2,3,4-Tetrahydroisoquinoline, Verfharen zu ihrer Herstellung und ihre Verwendung als Kappa-Rezeptor Agonisten. Expired - Fee Related DE68910999T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888803919A GB8803919D0 (en) 1988-02-19 1988-02-19 Novel compounds
GB888815089A GB8815089D0 (en) 1988-06-24 1988-06-24 Novel compounds

Publications (2)

Publication Number Publication Date
DE68910999D1 DE68910999D1 (de) 1994-01-13
DE68910999T2 true DE68910999T2 (de) 1994-03-24

Family

ID=26293513

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89301374T Expired - Fee Related DE68910999T2 (de) 1988-02-19 1989-02-14 1,2,3,4-Tetrahydroisoquinoline, Verfharen zu ihrer Herstellung und ihre Verwendung als Kappa-Rezeptor Agonisten.

Country Status (12)

Country Link
US (1) US4954509A (de)
EP (1) EP0330360B1 (de)
JP (1) JPH0219379A (de)
AT (1) ATE97893T1 (de)
AU (1) AU620845B2 (de)
CA (1) CA1333067C (de)
DE (1) DE68910999T2 (de)
DK (1) DK75589A (de)
ES (1) ES2061972T3 (de)
IE (1) IE62031B1 (de)
NZ (1) NZ228032A (de)
PT (1) PT89746B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890012970A (ko) * 1988-02-23 1989-09-20 추후보충 테트라히드로 이소퀴놀린 유도체
GB8824400D0 (en) * 1988-10-18 1988-11-23 Glaxo Group Ltd Chemical compounds
GB8827479D0 (en) * 1988-11-24 1988-12-29 Zambeletti Spa L Novel compounds
GB8830219D0 (en) * 1988-12-23 1989-02-22 Zambeletti Spa L Novel compounds
DE3935371A1 (de) * 1988-12-23 1990-07-05 Merck Patent Gmbh Stickstoffhaltige ringverbindungen
GB8916395D0 (en) * 1989-07-18 1989-09-06 Zambeletti Spa L Pharmaceuticals
JPH05501551A (ja) * 1989-11-24 1993-03-25 スミスクライン　ビーチャム　ファルマシューティッチ　エッセ　ピ　ア アザ環式誘導体
GB8926560D0 (en) * 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
US5532243A (en) * 1992-02-14 1996-07-02 The Dupont Merck Pharmaceutical Company Antipsychotic nitrogen-containing bicyclic compounds
US5389638A (en) * 1993-09-10 1995-02-14 Abbott Laboratories Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitors
TW427978B (en) * 1996-02-03 2001-04-01 Hoffmann La Roche Tetrahydroisoquinoline derivatives
TW436484B (en) * 1996-04-24 2001-05-28 Dev Center Biotechnology 1,2,3,4-tetrahydroisoquinoline derivatives having a nitrogen-containing heterocyclic methyl substituent, the preparation process and pharmaceutical composition thereof
BR0316837A (pt) * 2002-12-02 2005-10-18 Pharmacia & Upjohn Co Llc Utilização de tetrahidroisoquinolinas 4-fenil substituìdas no tratamento da dor, enxaqueca e incontinência urinária
MXPA05005829A (es) * 2002-12-02 2005-08-29 Pharmacia & Upjohn Co Llc El uso de tetrahidroisoquinolinas 4-fenil-sustituidas en el tratamiento del dolor, dolores de cabeza migranosos e incontinencia urinaria.
WO2004050630A1 (en) * 2002-12-02 2004-06-17 Pharmacia & Upjohn Company Llc The use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence
JO3316B1 (ar) 2013-05-30 2019-03-13 Lilly Co Eli مركبات 3، 4-داي هيدرو أيزو كوينولين -2(1h)-يل
TWI725408B (zh) 2018-04-20 2021-04-21 美商美國禮來大藥廠 多巴胺d1受體正向異位調節劑

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2361390A1 (de) * 1973-12-10 1975-06-19 Merck Patent Gmbh Isochinolinderivate und verfahren zu ihrer herstellung
DE2504250A1 (de) * 1975-02-01 1976-08-05 Merck Patent Gmbh Tetrahydroisochinolin-derivate und verfahren zu ihrer herstellung
US4232160A (en) * 1978-10-18 1980-11-04 Miles Laboratories, Inc. Isoquinoline propionamides exhibiting analgesic properties
US4518779A (en) * 1982-09-27 1985-05-21 Pennwalt Corporation 1,2,3,4-Tetrahydro-1-aminomethyl-4-phenyl isoquinolines
GB8531615D0 (en) * 1985-12-23 1986-02-05 Zambeletti Spa L Compounds
GB8601796D0 (en) * 1986-01-24 1986-02-26 Zambeletti Spa L Compounds
KR890012970A (ko) * 1988-02-23 1989-09-20 추후보충 테트라히드로 이소퀴놀린 유도체
DE3935371A1 (de) * 1988-12-23 1990-07-05 Merck Patent Gmbh Stickstoffhaltige ringverbindungen

Also Published As

Publication number Publication date
NZ228032A (en) 1991-12-23
JPH0219379A (ja) 1990-01-23
IE890519L (en) 1989-08-19
ATE97893T1 (de) 1993-12-15
AU620845B2 (en) 1992-02-27
ES2061972T3 (es) 1994-12-16
EP0330360B1 (de) 1993-12-01
DE68910999D1 (de) 1994-01-13
CA1333067C (en) 1994-11-15
DK75589A (da) 1989-08-20
PT89746B (pt) 1994-03-31
US4954509A (en) 1990-09-04
AU3007089A (en) 1989-08-24
PT89746A (pt) 1989-10-04
DK75589D0 (da) 1989-02-17
IE62031B1 (en) 1994-12-14
EP0330360A1 (de) 1989-08-30

Similar Documents

Publication Publication Date Title
DE68910999T2 (de) 1,2,3,4-Tetrahydroisoquinoline, Verfharen zu ihrer Herstellung und ihre Verwendung als Kappa-Rezeptor Agonisten.
ATE126802T1 (de) Heterocyclische derivate.
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
AU5905790A (en) 2-acyl-1-(substituted aminomethyl-tetrahydroisoquinoline) derivatives
PT89677A (pt) Processo para a preparacao de novos derivados azaciclicos, em particular derivados de piperidina
ATE312150T1 (de) Electrochrome lösung, enthaltend eine hydrazonverbindung und mit dieser hergestellte vorrichtung
DK584488A (da) Isoquinolinderivater
DK0410953T3 (da) Piperidinforbindelser
HUP0003857A2 (hu) Eljárás alkoxi-furanon-amin-származékok előállítására, az eljárással kapott vegyületek és a vegyületek alkalmazása
SE8100743L (sv) Rifamycinderivat
ATE253048T1 (de) Verfahren zur herstellung von piperidincarbonsäureamiden
DE3664467D1 (de) Pineapple ketone l'alkoxyalkyl derivatives
TH2518A (th) อนุพันธ์เตตราไฮโดรไพริดาซิโนน กระบวนการเตรียมสารเหล่านี้และการใช้สารเหล่านี้
TH2518EX (th) อนุพันธ์เตตราไฮโดรไพริดาซิโนน กระบวนการเตรียมสารเหล่านี้และการใช้สารเหล่านี้
TH14707EX (th) สารต่อต้านประสาทสัมผัสรับการเร่งเร้าจากอะมิโนแอซิด

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee